drugset / Trial / NCT00188604
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
Phase 2
Completed
34 enrolled
University Health Network, Toronto
Princess Margaret Hospital, Canada · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The primary objective of this study to assess the effectiveness of selenium compared to placebo in reducing the lymphedema in-patients with breast cancer. Secondary objectives are to assess the impact of selenium on patient's quality of life and to assess the incidence of adverse effects of selenium therapy.
Timeline
- Start
- 2004-01
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium selenite | Unknown | — | — |